Copenhagen, Denmark

Rune Viig Overgaard

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Copenhagen, DE (2018)
  • Copenhagen, DK (2020)

Company Filing History:


Years Active: 2018-2020

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: The Innovations of Rune Viig Overgaard

Introduction

Rune Viig Overgaard is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of anti-KIR antibodies. With a total of 2 patents to his name, Overgaard's work is paving the way for advancements in cancer treatment.

Latest Patents

Overgaard's latest patents focus on anti-KIR antibodies, specifically a novel IgG4 isotype anti-KIR antibody. These patents detail innovative formulations and methods for using these antibodies. The patents also describe compositions, formulations, dosages, and administration regimens that are suitable for natural killer (NK) cell activation and therapeutic applications. Additionally, the patents include kits that comprise one or more anti-KIR antibodies, complete with instructions for use in treating cancer.

Career Highlights

Rune Viig Overgaard is currently associated with Novo Nordisk A/S, a leading global healthcare company. His work at Novo Nordisk emphasizes the importance of research and development in the biotechnology sector. Overgaard's contributions are instrumental in advancing therapeutic options for patients.

Collaborations

Overgaard collaborates with esteemed colleagues such as Peter Andreas Nicolai Reumert Wagtmann and Ivan Svendsen. These partnerships enhance the research efforts and innovation within the field.

Conclusion

Rune Viig Overgaard's innovative work in the development of anti-KIR antibodies represents a significant advancement in cancer treatment. His contributions to biotechnology are noteworthy and continue to impact the healthcare industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…